Small molecule TGF-beta mimetics as potential neuroprotective factors

Current Alzheimer Research

Volumn 2, Issue 2, 2005, Pages 183-186

  Zhang, Hui ^c   Zou, Kun ^c   Tesseur, Ina ^c   Wyss Coray, Tony ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; BRAIN INJURY; CONFERENCE PAPER; DEGENERATIVE DISEASE; DEMENTIA; ECONOMIC ASPECT; IMMUNE RESPONSE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL ASPECT;

ALZHEIMER DISEASE; ANIMALS; BIOMIMETIC MATERIALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; MICE; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 20844450231     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567205053585756     Document Type: Conference Paper

References (15)

1. Terry RD, Masliah E and Hansen LA. In: Alzheimer Disease, (Ed: Terry RD, Katzman R and Bick KL), Raven Press New York, p. 179-196(1994).
2. Wyss-Coray T, Lin C, Van F, Yu G, Rohde M, McConlogue L, et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med 7: 614-618 (2001).
3. Brionne TC, Tesseur I, Masliah E, Wyss-Coray T. Loss of TGF-beta1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40: 1133-1145 (2003).
4. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700 (2003).
5. Dennler S, Goumans M-J, Dijke Pt. Transforming growth factor β signal transduction. J. Leukoc Biol 71: 731-740 (2002).
6. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. TGF-β1 is an organizer of responses to neurodegeneration. J Cell Biochem 53: 314-322 (1993).
7. Flanders KC, Ren RF, Lippa CF. Transforming growth factor-βs in neurodegenerative disease. Prog Neurobiol 54: 71-85 (1998).
8. Buckwalter M, Wyss-Coray T. Modelling neuroinflammatory phenotypes in vivo. J Neuroinflammation 1: 10 (2004).
9. Krieglstein K, Richter S, Farkas L, Schuster N, Dunker N, Oppenheim RW, et al. Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat Neurosci 3: 1085-1090 (2000).
10. Dünker N, Schuster N, Krieglstein K. TGF-β modulates programmed cell death in the retina of the developing chick embryo. Development 128: 1933-1942 (2001).
11. Wyss-Coray T, Lin C, Sanan D, Mucke L, Masliah E. Chronic overproduction of TGF-β1 in astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 156: 139-150 (2000).
12. Massague J, Blain SW, Lo RS. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309 (2000).
13. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahue PK, et al. Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogensis. Proc Natl Acad Sci USA 97: 2626-2631 (2000).
14. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 21: 1743-1753 (2002).
15. Dennler S, itoh S, Vivien D, Dijke PT, Huet S, Gauthier J-M. Direct binding of smad3 and smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17; 3090-3100 (1998).